The cost associated with managing nephrotoxicity among vancomycin-treated patients in an intensive care unit

British Journal of Intensive Care

Volumn 10, Issue 3, 2000, Pages 78-86

  Guest, J F ^a   Roberts, G ^a   Baguley, J ^a   Palazzo, M ^a  

^a CATALYST Health Economics Consultants   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; AMPHOTERICIN; CREATININE; FUROSEMIDE; GENTAMICIN; HEPARIN; MANNITOL; VANCOMYCIN;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CREATININE BLOOD LEVEL; DRUG COST; FEMALE; HEMOFILTRATION; HOSPITAL RUNNING COST; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; UNITED KINGDOM;

EID: 0034462297     PISSN: 09617930     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981
2. Nephrotoxicity of vancomycin, alone and with an aminoglycoside
3. Vancomycin toxicity: A prospective study
4. A prospective study of adverse reactions associated with vancomycin therapy. J Antimicrob Chemother
5. Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination
6. The development of vancomycin
7. Vancomycin use - An historical review
8. Community-acquired methicillin resistant Staphylococcus aureus endocarditis in the Detroit Medical Center
9. Vancomycin: An update
10. Vancomycin therapy for methicillin-resistant Staphylococcus aureus
11. Treatment of infections due to methicillin-resistant Staphylococcus aureus
12. Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak
13. Monitoring vancomycin therapy
14. Mild nephrotoxicity associated with vancomycin use
15. Hemofiltration in a cardiac intensive care unit: Time for a rational approach
16. Risk factors and outcome of hospital-acquired acute renal failure
17. What is the cost of nephrotoxicity associated with aminoglycosides?